Skip to main content
Fig. 5 | BMC Cancer

Fig. 5

From: A network meta-analysis for efficacies and toxicities of different concurrent chemoradiotherapy regimens in the treatment of locally advanced non-small cell lung cancer

Fig. 5

Comparison-adjusted funnel plots of efficacies and toxicities of different CCRT regimens. A Comparison-adjusted funnel plots of efficacies of different CCRT regimens. B Comparison-adjusted funnel plots of toxicities of different CCRT regimens. A = CCRT (cisplatin + etoposide). B = CCRT (carboplatin + paclitaxel). C = CCRT (pemetrexed + carboplatin). CCRT = concurrent chemoradiotherapy. D = CCRT (pemetrexed + cisplatin). E = CCRT (docetaxel + cisplatin). F = CCRT (S-1 + cisplatin). G = CCRT (mitomycin + vindesine + cisplatin). H = CCRT (cisplatin + vinorelbine). I = CCRT (cisplatin). K = RT. L = CCRT (5-FU). M = CCRT (paclitaxel + cisplatin). N = CCRT (irinotecan + carboplatin). O = CCRT (nedaplatin). ORR = overall response rate. OS = overall survival. P = CCRT (carboplatin + etoposide). Q = CCRT (paclitaxel). R = CCRT (carboplatin)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us